McFarlane Neil F. is a director of Collegium Pharmaceutical Inc.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ZEVRA THERAPEUTICS, INC.
2 Feb 24
4
ZEVRA THERAPEUTICS, INC.
11 Oct 23
3
ZEVRA THERAPEUTICS, INC.
10 Oct 23
4
COLLEGIUM PHARMACEUTICAL, INC
19 May 23
4
COLLEGIUM PHARMACEUTICAL, INC
23 May 22
4
COLLEGIUM PHARMACEUTICAL, INC
8 Apr 22
3
COLLEGIUM PHARMACEUTICAL, INC
8 Apr 22
4
Adamas Pharmaceuticals Inc
24 Nov 21
4
Adamas Pharmaceuticals Inc
3 Mar 21
4
Adamas Pharmaceuticals Inc
20 Mar 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 24 | ZVRA Zevra Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 700,000 | 0.00 | 700,000 |
10 Oct 23 | ZVRA Zevra Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 200,000 |
10 Oct 23 | ZVRA Zevra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.75 | 600,000 | 2.85 mm | 600,000 |
18 May 23 | COLL Collegium Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 9,792 | 0.00 | 41,672 |